acquired
Stage
About
Agensys was a US-based biotechnology company developing antibody therapeutics, focusing on monoclonal antibody technology for oncology applications; it was acquired by Astellas in 2007 for up to $537 million.
Explore Agensys's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.